|
|
|
|
|
|
Free Newsletters
Archive
My eNewsletters
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Login
Become a Member
Discussion Forums
FAQ
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
Immucor (BLUD) Adds Director To Board
5/15/2006
NORCROSS, Ga., May 15 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that Michael S. Goldman has agreed to join Immucor's Board of Directors effective immediately. Mr. Goldman is a Managing Director and founding principal of TM Capital Corp., a New York and Atlanta investment bank which focuses on assisting public and private client companies in completing mergers, acquisitions and financings which build shareholder value. TM Capital has represented Immucor on a number of transactions.
Commenting on this addition to the Board of Directors Edward L. Gallup, Chairman and Chief Executive Officer stated, "We are extremely pleased to have an individual with the expertise and background that Michael brings to our Board. Mr. Goldman has been an advisor to several other public health care companies and also is currently a director of three privately held companies. His experience will be extremely valuable as the Company and its Board of Directors address our future."
Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of our market segments.
For more information on Immucor, please visit our website at http://www.immucor.com.
Immucor, Inc.
CONTACT: Edward Gallup of Immucor, Inc., +1-770-441-2051
|
|
|
|
|
|
|
|
|
|
|
|